Kbc Group Nv Krystal Biotech, Inc. Transaction History

Kbc Group Nv

$33.1 Billion
Q3 2024

A detailed history of Kbc Group Nv transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 642 shares of KRYS stock, worth $101,769. This represents 0.0% of its overall portfolio holdings.

Number of Shares

642

Previous 510 25.88%

Holding current value

$101,769

Previous $94,000 24.47%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$174.7 - $213.66 $23,060 - $28,203	132 Added 25.88%	642 $117,000
Q2 2024 Jul 17, 2024	BUY	$153.12 - $183.64 $5,665 - $6,794	37 Added 7.82%	510 $94,000
Q4 2023 Feb 13, 2024	BUY	$96.0 - $128.29 $45,408 - $60,681	473 New	473 $59,000
Q4 2021 Feb 03, 2022	SELL	$39.81 - $88.24 $78,624 - $174,274	-1,975 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$37.03 - $60.0 $59,248 - $96,000	1,600 Added 426.67%	1,975 $82,000
Q4 2019 Feb 11, 2020	SELL	$33.17 - $65.23 $178,786 - $351,589	-5,390 Reduced 93.5%	375 $21,000
Q3 2019 Nov 07, 2019	BUY	$34.72 - $51.3 $86,452 - $127,737	2,490 Added 76.03%	5,765 $200,000
Q2 2019 Dec 03, 2019	BUY	$27.2 - $41.2 $89,080 - $134,930	3,275 New	3,275 $132,000
Q2 2019 Jul 30, 2019	SELL	$27.2 - $41.2 $89,080 - $134,930	-3,275 Closed	0 $0
Q1 2019 Dec 03, 2019	BUY	$19.86 - $32.9 $65,041 - $107,747	3,275 New	3,275 $108,000
Q1 2019 May 10, 2019	SELL	$19.86 - $32.9 $58,090 - $96,232	-2,925 Closed	0 $0
Q4 2018 Dec 03, 2019	BUY	$15.03 - $25.38 $43,962 - $74,236	2,925 New	2,925 $61,000
Q4 2018 Jan 31, 2019	SELL	$15.03 - $25.38 $33,441 - $56,470	-2,225 Closed	0 $0
Q3 2018 Dec 03, 2019	BUY	$14.43 - $21.0 $32,106 - $46,725	2,225 New	2,225 $39,000
Q3 2018 Nov 14, 2018	SELL	$14.43 - $21.0 $32,106 - $46,725	-2,225 Closed	0 $0
Q2 2018 Dec 03, 2019	BUY	$8.99 - $15.26 $20,002 - $33,953	2,225 New	2,225 $33,000
Q2 2018 Aug 03, 2018	SELL	$8.99 - $15.26 $20,002 - $33,953	-2,225 Closed	0 $0
Q1 2018 Dec 03, 2019	BUY	$8.61 - $11.74 $19,157 - $26,121	2,225 New	2,225 $22,000
Q1 2018 May 09, 2018	SELL	$8.61 - $11.74 $8,610 - $11,740	-1,000 Closed	0 $0
Q4 2017 Dec 03, 2019	BUY	$8.19 - $11.19 $8,189 - $11,190	1,000	1,000 $11,000

Others Institutions Holding KRYS

# of Institutions

310

Shares Held

24.3M

Call Options Held

483K

Put Options Held

364K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.07B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account